BI Asset Management Fondsmaeglerselskab A/S
Position in LH — Labcorp Holdings Inc.
CIK 1778131
KOBENHAVN, G7
Position in LH
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,520,400
+$772,532 QoQ
Shares Held
5,430
+93.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#400
of 1,044 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026BI Asset Management Fondsmaeglerselskab A/S holds $70,749,968 across 13 Diagnostics & Research names. LH ranks #10 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
75,918 | $38,062,248 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
22,217 | $11,765,901 | |
| 3 | DHR |
Danaher Corp /De/
|
30,517 | $5,812,878 | |
| 4 | ILMN |
Illumina, Inc.
|
13,975 | $2,457,224 | |
| 5 | A |
Agilent Technologies, Inc.
|
17,013 | $2,259,836 | |
| 6 | WAT |
Waters Corp /De/
|
5,114 | $1,917,954 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
3,229 | $1,699,874 | |
| 8 | DGX |
Quest Diagnostics Inc
|
7,925 | $1,679,703 |
All Filings in LH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,520,400 | 5,430 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $747,868 | 2,803 | Shares | Defined | 2026-04-16 | |
| 2025-12-31 | $1,029,862 | 4,105 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,204,216 | 4,195 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $1,093,354 | 4,165 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $742,673 | 3,191 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $446,715 | 1,948 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $918,055 | 4,108 | Shares | Defined | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||